ClinicalTrialsFinder
RecruitingNCT06270771

OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

Sponsor

Sunnybrook Health Sciences Centre

Enrollment

60 participants

Start Date

Mar 20, 2025

Study Type

OBSERVATIONAL

Conditions

MDSMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsRARS-T

Summary

A prospective, single center, single arm phase 2 cohort feasibility study of the OURA ring in adult MDS patients. Patients with MDS will wear the OURA ring and upload biometrics weekly. Quality of life measures will be clinically evaluated and correlated with biometrics. We hypothesize that it will be feasible for MDS patients to wear the OURA ring 70% of the time for 3 months.

Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, aged 18 or older
  • Able to read, write and speak English or French (non-English or French speaking patients may participate if appropriate translation is used)
  • Diagnosed with Myelodysplastic Syndrome using WHO 2022 criteria (12) all risk groups
  • Ability to wear the OURA ring and operate the associated smart-phone app, and willing to adhere to the study regimen

Exclusion Criteria2

  • Performance status ECOG > 3.
  • Cognitive or physical impairment preventing the usage or utilization of the OURA ring and smart phone.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOURA Ring

The OURA ring (https://ouraring.com) is a light-weight wearable device in the form of a ring that has several microsensors enabling detection of heart rate, blood oxygen level, skin temperature, and movement. The OURA ring and application can synthesize the sensory data to generate physiologic information such as sleep, activity level, resting heart rate, heart rate variability, respiratory rate, and more. The OURA ring is water resistant and has up to 5-7 days of battery life and can be fully charged in 20-80 minutes. It communicates with the OURA app and commonly used Smartphone health apps via Bluetooth connectivity with automatic syncing every week.

Locations(1)

Sunnybrook Health Sciences Research Centre

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06270771

Related Trials

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT0532019824 locations

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

NCT063031931 location

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

NCT018611061 location

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

NCT0495391022 locations

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

NCT0495389721 locations